Fig. 1From: Drug resistance in ovarian cancer: from mechanism to clinical trialThe summery of miRNA-mediated resistance mechanisms (a) Abnormal transmembrane transport; (b) Alterations of DNA damage repair; (c) Dysregulation of cancer-associated signal pathway; (d) Epigenetic modificationBack to article page